Compare Health Catalyst, Inc. with Similar Stocks
Stock DNA
Software Products
USD 89 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
0.20
-20.58%
0.27
Revenue and Profits:
Net Sales:
75 Million
(Quarterly Results - Dec 2025)
Net Profit:
-91 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-53.78%
0%
-53.78%
6 Months
-60.85%
0%
-60.85%
1 Year
-75.39%
0%
-75.39%
2 Years
-85.27%
0%
-85.27%
3 Years
-90.48%
0%
-90.48%
4 Years
-95.61%
0%
-95.61%
5 Years
-97.65%
0%
-97.65%
Health Catalyst, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
12.03%
EBIT Growth (5y)
4.20%
EBIT to Interest (avg)
-8.75
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.12
Sales to Capital Employed (avg)
0.50
Tax Ratio
0.60%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.27
EV to EBIT
-2.92
EV to EBITDA
-30.47
EV to Capital Employed
0.39
EV to Sales
0.49
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-13.33%
ROE (Latest)
-20.58%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
Bearish
OBV
No Trend
Bearish
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 54 Schemes (32.88%)
Foreign Institutions
Held by 85 Foreign Institutions (7.22%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
Dec'25
Sep'25
Change(%)
Net Sales
74.70
76.30
-2.10%
Operating Profit (PBDIT) excl Other Income
5.10
-1.90
368.42%
Interest
5.50
5.60
-1.79%
Exceptional Items
-78.30
-3.00
-2,510.00%
Consolidate Net Profit
-91.00
-22.20
-309.91%
Operating Profit Margin (Excl OI)
-104.50%
-190.70%
8.62%
USD in Million.
Net Sales
QoQ Growth in quarter ended Dec 2025 is -2.10% vs -5.45% in Sep 2025
Consolidated Net Profit
QoQ Growth in quarter ended Dec 2025 is -309.91% vs 45.85% in Sep 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
311.10
306.60
1.47%
Operating Profit (PBDIT) excl Other Income
9.80
-13.30
173.68%
Interest
24.30
17.10
42.11%
Exceptional Items
-120.20
-15.10
-696.03%
Consolidate Net Profit
-178.00
-69.50
-156.12%
Operating Profit Margin (Excl OI)
-130.80%
-178.60%
4.78%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 1.47% vs 3.62% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -156.12% vs 41.15% in Dec 2024
About Health Catalyst, Inc. 
Health Catalyst, Inc.
Software Products
Health Catalyst Inc. is a provider of data and analytics technology and services to healthcare organizations. Its solution comprises a cloud-based data platform, analytics software, and professional services expertise. Its cloud-based data operating system (DOS) is a healthcare-specific, open, flexible, and scalable data platform that provides customers a single comprehensive environment to integrate and organize data from their disparate software systems, enabling a broad range of analytics. Its software analytics application is build on top of its data platform to provide foundational or domain-specific insights that improve customers’ clinical, financial, and operational performance. It serves the majority of customers through a subscription-based contract model. Its offered services include opportunity analysis and prioritization, data modeling and analysis, quality and process improvement strategy, and population health strategies. It offers its services to healthcare providers.
Company Coordinates 
Company Details
3165 E Millrock Dr Ste 400 , SALT LAKE CITY UT : 84121-4772
Registrar Details






